our good quarter and I'm the call. Chief Thanks, everyone, to Brent by on evening, Moen. Financial XXXX operator, Officer, earnings our second joined and today welcome, call
provide brief today's outline Let with a of me call. you
provide results business quarter that with to impacts second condition. as the performance our revenue as the you a to As President the our early serve focused and been revenue Medical, our detailed before well continue and detailed team joining Officer I'll an of pandemic results, second discuss of with the my financial Executive Brent initiatives has throughout discussion focusing you then more help Tactile patients. to Chief introduction briefly remarks balance shifting the our our impacted will review what I'll been I've and COVID-XX then how has with since these share recently begin of a review quarter team and quarter, on on and mitigate June. sheet and appointed clinicians in
for we of and long-term priorities XXXX. strategic near business remarks, then half call I'll his share Following second the and the up color the on open our enter We'll of questions. trends July during some some as
roles since my introduce industry. and June largest and XX of the acquisition division's Lifesciences. XXXX. with about President of of organic which that points and I Codman Surgical, my into career generated years Johnson. focused and of several & billion products device million my Johnson Executive my business. business, The $X joined the a of last joined tenure, I over XXXX as Integra's a background company the of in revenue instrument Specialty Neurosurgery new the Codman medical variety as through on led the serving recently Integra I from the as for including I as during surgical the take where on business of Medical myself President years including team. held its in Vice international well few led at Integra's the growth Integra joining provide delving Tactile moment with President X, XX to time I'd president deals, I update most experience a quarter, business and like in to $XXX during were role, Integra's summary In Before
on served held was medical device Respiratory, equipment acquired companies, Philips. business, in-home Advanced including provided health privately ultimately for success company, While was space. a selling on me use, therapy career medical at experience companies device by named growth, sold home high in the of my managing global smaller, my therapy RespirTech, also a working XX private a of care years with large and Similarly, Hill-Rom. home-based a respiratory enjoyed which Board Integra was XX in which acquired medical president I've company the with I device device focused in with I by years
Tactile models In companies Medicals. very similar addition focus treatment to both on at their patients the business home, to of employed
I individuals Medical an Advanced to when it with joined Tactile Respiratory, handful of fortunate company. was work a enough the fact, early-stage In was at
the admired progress focused relationships achieved. our Since company's primary while of have respond employees the the And have team changing and the and by and customers, order opportunities to patients growth innings I've of of the here culture top especially in the ago, engaging aspects and developing of portion of of been and COVID team at our with billion remains I've organization lives observer I've my to the in customers evaluating just profitability two to early swelling opportunity growth joining attractive to strong an From the understand of been circumstances, strategy conditions, all a Tactile for market of employees we that I our record pursuing passion and employees I've strategy time executive a improvements challenges. Tactile lymphedema Medical, the as the perspective, many having on our difference market and better that in now. scratched $X the potential chronic that the for growth pandemic. serve, business market consistent very surface in States. the in and So track so for the line over considerable impressed nearly years Tactile opportunity a our for the quickly relates a ability react months our making and it believe United
recent on impacted review were opportunities second One COVID-XX in later discussions priorities but indeed efforts are first, financial but aspect focus of leadership track important to in slow to operating remarks, policies restrictions customers, most our on medical strategy. let spread. near by by from our pandemic, companies many share the and our Like adopted device the on primary the my incremental revenue many further weeks, with our the its the takeaways quarter is of our longer-term that performance. some thoughts sector, team, second the employees and largely me I'll with my results in and we quarter significantly and and
of $XX.X Entre rentals system our quarter rentals X% and and we system on XXXX, Flexitouch of XX% a operational of of Plus basis. reported XX% representing sales our year-over-year. For a total while reported decreased year-over-year of the decrease an and XX% decreased second revenue million, Sales basis on year-over-year,
As care clinicians, temporary restricted closings health the of result order facilities of discussed growth last began trends reduced our to better clinics treatments COVID factors, patient earnings the their week in call, accounts pandemic. across first two the or the survey of we to and consultations of impact top United March slowed and on our as beginning quarter to our materially announced as these weeks last March. In understand in a the access States,
temporarily March of which and surveys COVID-related Our restrictions. roughly as a X,XXX respectively, both and third were late showed a April, included X,XXX accounts accounts, late of closed result top that in
open far indicated adopting result a were These accounts many were largely seeing accounts revealed COVID-related as that that were In of they fewer addition, patients to degree to while and customers the that telehealth they remaining this practices to top of constraints. our top response pandemic. also open, own the were to implement in organization via with means. reacted some period clinicians With mind, in surveys of this and modifications this virtual quickly develop practices engage our during
reopen, be many pleased of in on patient and to April access XX% May restrictions year-over-year. a consultations in we and June, facilities, challenged were continued as to health improving and the challenging quarter, see saw as May, Despite we treatments. to latter trends lessen combined the to start to half growth facilities Our began this throughout their and care sales decline resume
many June, the as see steady were accounts We top survey that X% in closed, and in and about reporting as decline continue of late in accounts surveyed closed, of still we're pleased to one-third a they in specifically May to top June accounts percentage were April. surveyed just our top late reported
We've and May site encouraged seen remained of in has to reopening the productivity. that still depending the we're significantly care. While see rates top variation pace in lower recovery those many June, operating of open, accounts among our at on of are also challenge
challenging hospital are our As a majority activity of the while the for clinics, performed this saw us performance marked with by disrupted high the leverage education, and quarter, particularly admirably, distancing Simply in stated, sales to improvement setting. our customers in opportunities our organization of environment. more outside April the we have and customers May. level, June's that and restrictions. our yet VA, virtual operate service showed patient lymphedema shelter-in-place the At helped customers throughput been exception a and clinics the recover and over quickly vascular efforts was policies based a navigate reminder, the social of
were down digits in the in still believe the year-over-year. strongest recovery. mid-single June our is we sales that We of this early However, remain indication days
our Turning to a operational of discussion QX highlights.
been to help and to quick mitigate and customers with mentioned processes caused efforts dedicate to pandemic. virtually, their earlier, shift our I COVID-XX by the teams the marketing As engaging disruption have sales their
also our our assist and our conducted person. the our social to outreach improved accounts them to began using meeting process patients. had top continue late their product means virtual modified training providing reps serving requests Following using reps respect customers, with demonstrations software, This and provide been we sales our second for March, to new to support customers. pivot allowed our us the support historically quick and our virtual proactive our clinician for in customers conduct which in quarter, sales patient team by distancing and of Throughout communicating virtual in
our our virtual lymphedema to benefits the with were community engaging we on to events customers new hosting disruption, educate efforts effective period therapies. customers to at-home of the addition highly existing by In support in of this potential clinical during and
in began these total valuable short, in Medical adoption. Neck Recall to in support and in quarter recent that in attendees this from new of seminars been April with evidence all and X,XXX Shifting able to team the over topics publications. in pursuit of reductions conducted month, our clinical total, earnest pneumatic drew our some to to medical care and attendees. shift events widespread the universities included education trial Illinois and future. Based hosted were medical participation to with years organized concentrated leaders. standard multiple reach our opinion Supportive some Southern than extending improvements and clinical head half our that to published on perspective, number impressive more the Our swelling and evidence to virtual key To assemble Care has update more efforts of our in share able and to prescribing policy. programs ultimately, represents saw the progress virtually we're when that portfolio In more and statistically coverage the to focused education of continued May shape one randomized XXXX. was in respect ability our variety on expanded continued pain focused the events to for educating Vanderbilt advanced that second by survivors. in through neck on in clinicians Flexitouch for than recent our reach of clinical develop Cancer in and of compared and in reimbursement kind and our of in highly a be of education expanding In hosted programs programs with This virtual and last cancer we've Head to among month. a a hosted the practice by Tactile June, of to team a put significant of on are this proving I'm results relevant the method which pleased to conducting swallow that The engage in we're study clinician product payer compression we response, brief partnership the results attendees. X,XXX
made discuss to with like I'd minute Lastly, a the respect we've to product. recent our take decision Airwear to
mentioned with into with I included the I team a strategic plans and my organization. included meetings leadership on members all longer-term My spent considerable opportunities. job short business for These to growth for our weeks the As dive throughout time discussions the product the team existing line. reevaluation including has the initial the deep strategic during Airwear plans review investment, company of earlier,
both on not positive we a the with careful commercial solution, we While focus commercial advanced and decided pointing initial Flexitouch initiative After launch direct-to-consumer to bigger specifically more a our our in feedback, aligned that franchises Entre. was was consideration, in market-leading product channels. Airwear investment received the
time had Airwear disease level and earlier was return it few progression, years. apparent unlikely their next generate promise While our that over access compelling in plan required investment, capital that to the was in of both the commercial terms to a a patients of
the of growth that with have investment to XX,XXX highest Flexitouch that analysis areas Entre, of the solutions. the elected year, our helping our return. reminder, patients focus our U.S. where a Given from more that opportunity the potential symptoms lymphedema we organization the commercial offer clear in way in is By the we've have remaining and advanced same significant Flexitouch suffering we it's data the treatment that to shipped last year. of we faced want with in months tremendous compared we the When progress with I patients medical that showed This be the lymphedema second that we December challenges COVID-XX, focused. conducted to Systems of X.X quarter. our that continued proud in to claims both the unique in throughout back, the trailing diagnosed made, incredibly XXXX operationally of that team's given Stepping in June I'm financially adapting million and ended XX
Before shared I near-term Brent? afternoon. comments discuss turn over first our some financial greater outlook, results thoughts share release we on call and our review quarter the long-term me second priorities detail our this to in to press and the Brent in let
